Stockscreener 앱 받기
7.08
5.98%
-0.45
전일 마감가:
$7.53
열려 있는:
$7.75
하루 거래량:
25,442
Relative Volume:
0.46
시가총액:
$173.51M
수익:
$60,000
순이익/손실:
$-54.55M
주가수익비율:
-2.4062
EPS:
-2.9424
순현금흐름:
-
1주 성능:
-12.70%
1개월 성능:
-29.69%
6개월 성능:
-31.73%
1년 성능:
+0.00%
1일 변동 폭
$7.08
$7.99
1주일 범위
$7.08
$8.37
52주 변동 폭
$3.20
$21.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
명칭
Neonc Technologies Holdings Inc
전화
310 663 7831
주소
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ALNY, ARGX, INSM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
7.08 | 173.51M | 60,000 | -54.55M | 0 | -2.9424 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
Resistance Check: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2026 Gainers & Stock Timing and Entry Methods - baoquankhu1.vn
Dip Buying: What are analysts price targets for NeOnc Technologies Holdings Inc2026 Earnings Impact & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards - The Herald-Mail
NeOnc Technologies Holdings, Inc. Signs Material Definitive Agreements for Securities Purchase and Warrants – SEC Filing Details - Minichart
NeOnc Announces New Private Placement to Support Liquidity - TipRanks
NeOnc Technologies Launches Third Equity Round: Up to 545,583 Shares at $7.20, $1M First Close - TradingView
Breakouts Watch: What is the implied volatility of NeOnc Technologies Holdings Inc2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
NeOnc Technologies Holdings, Inc. announced that it expects to receive $3.928198 million in funding - marketscreener.com
Neonc Technologies (NTHI) to Release Earnings on Friday - Defense World
Swing Trade: Will NeOnc Technologies Holdings Inc benefit from government policyTrade Exit Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
NeOnc Technologies Appoints David Choi as Chief Accounting Officer to Strengthen Financial Leadership Amid Clinical Expansion - Minichart
Trade Recap: Does NeOnc Technologies Holdings Inc have declining or rising EPSQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
NeOnc Technologies Appoints New Chief Accounting Officer - TipRanks
Neonc appoints David Choi as Chief Accounting Officer - TradingView
NeOnc Technologies appoints David Choi as chief accounting officer - Investing.com India
Neonc Technologies Stock Price Dips 0.1% - National Today
NeOnc Technologies appoints David Choi as chief accounting officer By Investing.com - Investing.com Australia
NeOnc Technologies Holdings, Inc. Appoints David Choi as Chief Accounting Officer - marketscreener.com
NeOnc Technologies Appoints David Choi as Chief Accounting Officer - GlobeNewswire
NTHINeOnc Technologies Holdings Inc Latest Stock News & Market Updates - Stock Titan
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - marketscreener.com
Neonc Technologies (NASDAQ:NTHI) Trading Down 0.1% – Should You Sell? - Defense World
NeOnc sets Phase 2 dose for brain cancer drug NEO212 - Investing.com Nigeria
Surprises Report: Is NeOnc Technologies Holdings Inc. stock oversold or undervaluedPortfolio Return Report & Scalable Portfolio Growth Methods - Naître et grandir
NeOnc Reports Phase 1 NEO212 Results, Sets Phase 2 Dose - TipRanks
NeOnc Technologies Reports RP2D of 610 mg for Oral NEO212 after Phase 1 Dose-Escalation - TradingView
Breakouts Watch: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2025 Trading Volume Trends & Verified Stock Trade Ideas - baoquankhu1.vn
Published on: 2026-03-05 20:09:42 - baoquankhu1.vn
NeOnc Technologies settles dispute with Fox Infused for $737,920.77 payment - Investing.com Australia
NeOnc Technologies Settles Fox Infused Dispute With Payment - TipRanks
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - Bitget
Earnings Risk: Will NeOnc Technologies Holdings Inc benefit from government policy2025 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
NeOnc sets Phase 2 dose for brain cancer drug NEO212 By Investing.com - Investing.com Canada
NeOnc Technologies Holdings Reports Phase 1 Dose-Escalation Results and Determines Recommended Phase 2 Dose for Oral Neo212 - marketscreener.com
NeOnc Technologies Completes Late-February Private Equity Offerings - TipRanks
NeOnc to Present Initial NEO212 Phase 1 Data - TipRanks
NeOnc to present Phase 1 dose-escalation safety, PK data from NEO212-01 on March 4 - TradingView
NeOnc Technologies to present Phase 1 trial data on March 4 - Investing.com Nigeria
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity - Bitget
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NTHI Technical Analysis & ETF Price Forecast - Intellectia AI
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America - Sacramento Bee
User - The Chronicle-Journal
What are analysts’ price targets for NeOnc Technologies Holdings Inc.Bear Alert & Verified Momentum Stock Alerts - mfd.ru
Why NeOnc Technologies Holdings Inc. stock remains resilientPortfolio Growth Summary & Technical Analysis for Trade Confirmation - mfd.ru
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST) - The Desert Sun
Will NeOnc Technologies Holdings Inc. stock outperform value stocksEarnings Growth Report & Weekly Setup with ROI Potential - mfd.ru
Neonc Technologies Holdings Inc (NTHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
자본화:
|
볼륨(24시간):